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Fermentation of various foods by lactic acid bacteria (LAB) is one of the oldest forms of 
biopreservation practised by mankind. Bacterial antagonism has been recognized for over a century but 
in recent years this phenomenon has received more scientific attention, particulary in the use of 
various strains of lactic acid bacteria. One important attribute of LAB is their ability to produce 
antimicrobicrobial compounds called bacteriocin. In recent years, interest in the compounds has grown 
substantially due to their potential usefulness as natural substitute for chemical food preservatives in 
the production of foods with enhanced shelf life and/or safety. This balance is achived by its inhibitory 
effect upon the harmful pathogenic microorganisms. This paper presents some background on the 
scientific research about lactic acid bacteria as probiotics and their bacteriocins for healthy nutrition of 
fermented food. Probiotics had been of interest in the promotion of good health in animals and man. 
Some of the positive effects of probiotics are: growth promotion of farm animals, protection of host 
from intestinal infections, alleviation of lactose intolerance, relief of constipation, anticarcinogenic 
effect, anticholesterolaemic effects, nutrient synthesis and bioavailability, prevention of genital and 
urinary tract infections and imunostimulatory effects. 
 





Lactic acid bacteria (LAB) occur naturally in several raw 
materials like milk, meat and flour used to produce 
foods (Rodriguez et al., 2000). LAB are used as natural 
or selected starters in food fermentations in which they 
perform acidification due to production of lactic and 
acetic acids flavour. Protection of food from spoilage 
and pathogenic microorganisms by LAB is through 
producing organic acids, hydrogen peroxide, diacethyl 
(Messens and De Vugst, 2002), antifungial compounds 
such as fatty acids (Corsetti et al., 1998) or phenullactic 
acid (Lavermicocca et al., 2000) and/or bacteriocins (De 
Vugst and Vandamme, 1994). LAB play an important 
role in food fermentation as the products obtains with 
their aid are characterized by hygienic safety, storage 
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Many bacteria of different taxonomic branches and 
residing in various habitats produce antimicrobial 
substances that are active against other bacteria. Both 
Gram negative and Gram positive bacteria produce 
bacteriocins. Bacteriocins are proteinaceous 
antibacterial compounds, which constitute a 
heterologous subgroup of ribosomally synthesized 
antimicrobial peptides (De Vugst and Vandamme, 
1994). In general these substances are cationic 
peptides that display hydrophobic or amphiphilic 
properties and the bacterial membrane is in most cases 
the target for their activity. Depending on the producer 
organism and classification criteria, bacteriocins can be 
classified into several groups (Ennahar et al., 2000; 
Jack and Jung, 2000; Cleveland et al., 2001; McAuliffe 
et al.,  2001) in which classes I and II are the most 
thoroughtly studied. Class I, termed lantibiotics, 
constitue a group of small peptides that are 
characterized by their content of several unusual amino 
acids (Gruder et al., 2000). The class II bacteriocins are  
  




Table 1. Orla-Jensen (1919) key to differentiation of the lactic acid bacteria and current taxonomic classification. 
  
Genusa Shape Catalase Nitrite reduction Fermentation Current genera 
Betabacterium Rod - - Hetero Lactobacillus Weissella 
Thermobacterium Rod - - Homo Lactobacillus 
Streptobacterium Rod - - Homo Lactobacillus Carnobacterim 
Streptococcus Coccus - - Homo Streptococcus Enterococcus 
Lactococcus Vagococcus 
Betacoccus Coccus - - Hetero Leuconostoc Oenococcus Weissella 
Microbacterium Rod + + Homo Brochothrix 
Tetracoccus Coccus + b + Homo Pediococcus Tetragenococus 
 
aAccoring to Orla Jensen (1919). 




small, nonmodified, heat stable peptides (Nes and Holo, 
2000). Many bacteriocins are active against food borne 
pathogens (Vignolo et al., 1996; De Martins and 
Franco, 1998; Bredhott et al., 1999). 
A large number of bacteriocins have been isolated 
and characterized from lactic acid bacteria and some 
have acquired a status as potential antimicrobial agents 
because of their potential as food preservatives and 
antagonistic affect against important pathogens. The 
important ones are nisin, diplococcin, acidophilin, 
bulgarican, helveticins, lactacins and plantaricins 
(Nettles and Barefoot, 1993). The lantibiotic nisin which 
is produced by different Lactococcus lactis spp. is the 
most thoroughtly studied bacteriocin to date and the 
only bacteriocin that is applied as an additive in food 
worldwide (Delves Broughton et al., 1996). One of the 
reason for increased consumption of fermented milk 
products is that fermented dairy products containing 
probiotics which have many proposed health benefits 
are available on the market. In this paper the diversity 
of bacteriocins their appliction and lactic acid bacteria 
used are probiotics are reviewed. 
 
 
Taxonomy of lactic acid bacteria 
 
The classification of LAB was initiated in 1919 by Orla-
Jensen (Table 1) and was until recently primary based 
on morphological, metabolic and physiological criteria. 
Lactic acid bacteria comprise a diverse group of Gram-
positive, non spore forming, non motile rod and coccus 
shaped, catalase-lacking organisms. They are chemo-
organotrophic and only grow in complex media. 
Fermentable carbohydrates and higher alcohols are 
used as the energy source to form chiefly lactic acid. 
LAB degrades hexoses to lactate (homofermentatives) 
or lactate and additionnal products such as acetate, 
ethanol, CO2, formate or succinate (heterofermen-
tatives). They are widely distributed in different 
ecosytems and are commonly found in foods (dairy 
products, fermented meats and vegetables, sourdough, 
silage, beverages), sewage, on plants but also in the 
genital, intestinal and respiratory tracts of man and 
animals. 
Current methodolgies used for classification of LAB 
mainly rely on 16S ribosomal ribonucleic acid (rRNA) 
analysis and sequencing (Olsen et al., 1994). Based on 
these techniques, Gram-positive bacteria are divided 
into two groups depending on their G + C content. The 
Actinomycetes have a G + C content above 50 mol% 
and contain genera such as Atopobium, Bifidobac-
terium, Corynobacterium and Propionibac-terium. In 
contrast, the Clostridium branch has a G + C content 
below 50 mol% and include the typical LAB genera 
Carnobacterium, Lactobacillus, Lactococcus, Leuconos-
toc, Pediococcus and Streptococcus. 
 
 
Lactic acid bacteria as probiotics 
 
Lactic acid bacteria were referred to as probiotics in 
scientific literature by Lilley and Stillwell (1965). 
However probiotic took on a different terminology when 
Sperti (1971) used the term « probiotic » to describe 
tissue extracts that stimulated microbial growth. Parker 
(1974) redefined it as organisms and substances that 
contribute to the intestinal microbial balance. The most 
recent and accurate description of probiotics was 
undertaken by Fuller (1989) who redefined it as « a live 
microbial feed supplement beneficial to the host (man 
or animal) by improving the microbial balance within its 
body ». Another recent definition was by Schrezenmeir 
and De Vrese (2001) who defined probiotics as viable 
microbial food supplements which beneficially influence 
the health of the host. 
The gastrointestinal tract contains food in different 
stages of digestion, digestive ferments, liquids and solid 
waste. Within the gut are also wide ranges of microbes 
that may be either harmful or beneficial. The beneficial 
ones assist in the breakdown of food while they also 
manufacters vitamins essential to the body, breaking 
down  and destroying   some  toxic  chemicals that  may  
  




have been ingested with the food. Under both healthy 
and sick conditions, several differnt types of bacteria 
compete or fight with each other to establish dominance 
in the warm and moist environment of the alimentary 
canal that serves as an ecosystem for their survival and 
propagation. The average human large intestine 
harbors over 400 different special of bacteria with a 
total population far outnumbering even the number of 
human cells in the body. Under ideal conditions of 
health and diet, the different strains of bacteria on 
microflora compete and check the excessive number of 
any one strain. Healthy condition can be achieved if a 
balance is maintened between the « good » and 
« bad » bacteria in the ratio of 85 percent to 15 percent. 
Oral supplement of diet with viable Lactbacillus 
acidophilus of human origin, which is bile resistant, led 
to a significant decline of three different fecal bacterial 
enzymes (Goldin and Gorbach, 1977). This decrease in 
the fecal bacterial enzyme activity observed in both 
humans and rats included beta glucuronidase, 
azoreductase and nitroreductase. All these enzymesca-
talyse the conversion of procarcinogens to proximal 
carcinogens in the large bowel leading to    colon 
cancer. 
Lactic acid bacteria including Lactobacillus, 
leuconostoc, lactococcus, pediococcus and Bifidobacte-
rium are found throughout the gastrointestinal tract. The 
predominant population of lactic acid bacteria in the 
upper gastrointestinal tract is the Lactobacillus species 
which may colonize the mucosal surface of the 
duodenum as well as the stomach. Lactobacillus and 
Bifidobacterium spp. are prominent members of the 
commensal intestinal flora and are the commoly studied 
probiotics bacteria. They cause reduced lactose 
intolerance alleviation of some diarrhoeas, lowered 
blood cholesterol, increased immune response and 
prevention of cancer (Marteau and Ramband, 1993, 
1996; Gilliland, 1996; Salminen et al., 1998a).   The   
selection criteria for probiotic LAB include: human 
origin, safety, viability/activity in delivery vehicles, 
resistance to acid and bile, adherence to gut epithelial 
tissue ability to colonise the gastro intestinal tract, 
production of antimicrobial substances, ability to 
stimulate a host immune response and the ability to 
influence metabolic activities such as vitamin 
production, cholesterol assimulation and lactose activity 
(Salminen et al., 1996). 
Fuller (1989) and Conway (1996) listed the following 
organisms as species used in probiotic preparation: 
Lactobacillus acidophilus, Lactobacillus casei, 
Lactobacillus casei subsp. rhamnosus, Lactobacillus 
fermentum, Lactobacillus reuteri Lactococcus lactis 
subsp. lactis, Lactococcus lactis subsp. cremoris, 
Lactobacillus bulgaricus, Lactobacillus plantarum, 
Streptococcus thermophilus, Enterococcus faecium, 
Enterococcus faecalis, Bifidobacterium bifidum, Bifido-
bacterium infantis, Bifidobacterium adolescentis, 





Probiotics benefit in the gastro intestinal tract and 
immune system 
 
Certain LAB species are found not only as components 
of the human intestinal microflora but also of the man 
made ecosytem present in fermented food. That is why 
fermented milks containing viable LAB are known to be 
beneficial to healh acting as prophylaxis against 
intestinal infections. Thus many investigators have 
evaluated the effect of yoghurt on the immuno response 
of animals and humans. 
Many studies have been conducted on their effect on 
the incidence and duration of various types of diarrhoea 
(Isolauri, 2001; Bhatnagar et al., 1998). LAB can be 
effective in preventing gastrointestinal disorders and in 
the recovery from diarrhoea of miscellaneous causes 
(Marteau et al., 2001). A decrease in the severty and 
duration of persistent diarrhoea has been reported with 
LAB (Bhatnagar et al., 1998). Guandalini et al. (2000) 
also reported that the administration of Lactobacillus 
rhamnosus GG to 287 children aged 1- 36 months with 
acute diarrhoea significantly reduced the duration in 
infected children by rotavirus compared with those 
receiving placebo. Administration of Lb rhamnosus GG 
also shortened the duration of the hospital stay. 
 
 
CLASSIFICATION OF BACTERIOCINS 
 
The bacteriocins produced by Gram-positive bacteria 
like LAB are small peptides, 3-6 kDa, in size (Nes et al., 
1996), although there are exceptions (Jorger and 
Klaenhammer, 1990). On a sound scientific basis three 
defined classes of bacteriocins have been established: 
Class I, the lantibiotics; class II, the small heat stable 
non lantibiotics; and class III, large heat labile 
bacteriocins (Table 2). A fourth class of bacteriocins is 
composed of an undefined mixture proteins, lipids and 
carbohydrates. The existence of the fourth class was 
supported mainly by the observation that some 
bacteriocin activities obtained in cell free supernatant, 
exemplified by the activity of Lb plantarum LPCO 10 
were abolished not only by protease treatements, but 
also by glycolytic and lipolytic enzymes (Jimenez-Diaz 
et al., 1993). 
Most of the Gram positive bacteriocins are membrane 
active compounds that increase the permeability of the 
cytoplasmic membrane (Jack et al., 1995). They often 
show a much broader spectrum of bactericidal activity 
than the colicins (Gram negative bacteriocins which are 
produced by Esherichia coli). They fall with in two broad 
classes, viz the lantibiotics (Jack et al., 1995) and the 
non lantibiotic bacteriocins (Nes et al., 1996). Nisin 
(Table 3) prevents clostridal spoilage spoilage of 
processed and natural cheeses, inhibits the growth of 
some psychrotropic bacteria in cottage cheese, entends 
the shelf life of milk in warm countries, prevents the 
growth of spoilage lactobacilli in beer and wine 
fermentations and provides additional protection
  




Table 2. Antimicrobial peptides (peptide-bacteriocins) produced by lactic acid bacteria (Nissen-Meyer et al., 1997). 
 
Group I: Modified bacteriocins (the lantibiotics) Group II: Unmodified bacteriocins 
Type A Type B One peptide bacteriocins Two peptide bacteriocins 
Nisin Pediocin-like bacteriocins b: Lactococcin G 
Lactocin S Pediocin PA1, Leucocin A,  Lactacin F 
Lacticin 481 Sakacin P, Curvacin A, Plantaricin E/F 
Carnocin UI 49 
NK a 




 Carnobacteriocin BM1, 
Carnobacteriocin B2, 
Enterocin A, Piscicolin 126, 





  Nonpediocin- like bacteriocins: 
Lactococcin A and B, Crispacin A, 
Divergicin 750, Lactococcin 972, 




a Not known: lantibiotics of type B produced by lactic acid bacteria are presently not known 
b References for the pediocin like bacteriocins are: Pediocin PA1 (Henderson et al.,1992 ; Marug et al., 1992), leucocin A (Hastings et al., 
1991), sakacin P (Tichaczek et al., 1992 ), curvacin A (Tichaczek et al., 1992 ; Holck et al., 1992), mesentericin Y105 (Hechard et al., 1992), 
carnobacterioin BM1 and B2 (Quadri et al., 1994), enterocin A (Aymerich et al., 1996), piscicolin 126 (Jack et al. , 1996), bavaricin MN (Kaiser , 
Montville ,1996), piscicocin V1a (20). 
c Reference for plantaricin S: (Tichaczek et al., 1993). 
d originally published as a modified ine peptide bacteriocin (Cintas et al. , 1995), but recent results indicate that is an unmodified two-peptide 
bacteriocin (Cintas et al.unpublished results) 




Table 3. Properties of some well characterized bacteriocins (Soomro et al., 2002). 
 
Bacteriocin Producer organism Properties 
Nisin Lactococcus lactis subsp.lactis 
ATCC 11454 
Lantibiotic, broad spectrum, chromosome / plasmid mediated, 
bactericidal, produced late in the growth cycle Broad spectrum, plasmid 
mediated 
Pediocin A Pediococcus Pentosaceus FBB61 
and L-7230 
 
Pediocin AcH  Pediococus Acidilactici H Broad spectrum, plasmid mediated 
Leucocin Leuconostoc gelidum UAL 187 Broad spectrum, plasmid Mediated, bacteriostatic, produced early in the 
growth cycle  
Helveticin J 
Carnobacteriocn 
L.helveticus 481 Carnobacterium 
piscicola LV17 
Narrow spectrum, chromosomally mediated, bactericidal Narrow 




against Bacillus and clostridial spores in canned foods. 
Nisin is a permitted food additive in more than 50 
countries including the US and Europe under the trade 
name Nisaplin (Vandenberg, 1993; Delves-broughton et 
al., 1996). Nisin is active against many gram positive 





Bacteriocins are synthesized as pre-propeptide which 
are processed and externalised by dedicated transport 
machinery (Nes et al., 1996). Bacteriocin production in 
LAB is growth associated: it usually occurs throughout 
the growth phase and ceases at the end of the 
exponential phase (or sometimes before the end of 
growth (Parente et al., 1997; Lejeune et al., 1998). 
Bacteriocin production is affected by type and level of 
the carbon, nitrogen and phosphate sources, cations 
surfactants and inhibitors. Bacteriocins can be 
produced from media containing different carbohydrate 
sources. Nisin Z can be produced from glucose, 
sucrose and xylose by Lactococcus lactis IO-1 
(Matsuaki et al., 1996; Chinachoti et al., 1997a,b) but 
better results were obtained with glucose compared to 
xylose. Glucose followed by sucrose, xylose and 
galactose were the best carbon sources for the 
production of Pediocin  AcH  in  an  unbuffered  medium 
  




(Biswas et al., 1991). 
All bacteriocins are synthesized with an N terminal 
leader sequence and until recently only the double 
glycine type of leader was found in class II bacteriocins 
(Holo et al., 1991; Muriana and Klaenhammer, 1991; 
Klaenhammer, 1993; Havarstein et al., 1994). However, 
it has now been disclosed that some small, heat stable 
and non modified bacteriocins are translated with sec 
dependent leaders (Leer et al., 1995; Worobo et al., 
1995). The structural bacteriocin gene encodes a 
preform of the bacteriocin containing an N-terminal 
leader sequence (termed double glycine leader) whose 
function seems to prevent the bacteriocin from being 
biologicalhy active while still inside the producer and 
provide the recognition signal for the transporter 
system. 
A number of genes, often found in close proximity to 
each other are required for production of lantibiotics. 
These genes include: 
 
(a) The structural gene, lan A, 
(b) immunity genes (Lan I and in some cases Lan E, 
Lan F and Lan G) encoding proteins that protect the 
producer from the producer lantibiotic, 
 (c) a gene Lan T encoding what appears to be a 
membrane associated ABC transporter that transfers 
the lantibiotic across the membrane,  
(d) a gene, lan P, encoding a serine proteinase which 
removes the leader sequence of the lantibiotic 
prepeptide, 
(e) two genes, lan B and Lan C (or in some cases only 
one gene, Lan M), with no sequence similarity to other 
known gens thought to encode enzymes involved in the 
formation of lanthionine and methyl lanthionine, and 
(f) two genes lan k and lan R encoding two component 
regulatory proteins that transmit an extracellular signal 





The potential application of bacteriocins as consumer 
friendly biopreservatives either in the form of protective 
cultures are as additives is significant. LABS are 
typically involved in a large number of spontaneous 
food fermentations but they are also closely associated 
with the human environment. Food fermentations have 
a great economic value and it has been accepted that 
these products contribute in improving human health. 
LABS have contributed in the increased volume of 
fermented foods world wide especially in foods 
containing probiotics or health promoting bacteria. 
Bacteriocins produced by LAB are the subject of 
intense research because of their antibacterial activity 
against foodborne bacteria. 
Further studies should be focused on the 
mechanisms of action of LAB within the gastro intestinal 





vivo immunity effects. Furthermore, genetic engineering 
of already idenfied probiotics and those newly 
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